Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test

Anticancer Research

Volumn 21, Issue 6 B, 2001, Pages 4259-4263

  Rogala, Ewa ^a   Skopińska Rózewska, Ewa ^a   Sommer, Ewa ^a   Pastewka, Krzysztof ^a   Chorostowska Wynimko, Joanna ^a   Sokolnicka, Irena ^a   Kazoń, Miroslaw ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Angiogenesis; Growth factors; Urinary bladder carcinoma

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 8; VASCULOTROPIN;

ABSORPTION; ADULT; AGED; ANALYTIC METHOD; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TEST;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; CARCINOMA, TRANSITIONAL CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-8; LYMPHOKINES; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035574114     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Prognostic relevance of micro-vessel density in cancer of the urinary bladder
2. ctn in patients with transitional cell bladder cancer
3. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinoma
4. Expression of vascular endothelial growth factor in primary superficial bladder cancer
5. Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer
6. Different angiogenic pathways characterize superficial and invasive bladder cancer
7. Urinary vascular endothelial growth factor and its correlation with bladder cancer reccurence rates
8. Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma
9. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine
10. Implication of scatter/growth factors in tumor progression
11. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients
12. Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy
13. Thymidine phosphorylase is angiogenic and promotes tumor growth
14. Correlation of ovarian malignancy with expression of platelet-derived EC growth factor
15. Clinico-pathological and prognostic significance of an angiogenic factor, thymidyne phosphorylase in human coloretal carcinoma
16. Inhibitory effect of theobromine on induction of angiogenesis and VEGF MRNA expression in v-raf transfectants of human urothelial cells HCV-29
17. Inhibitory effect of shark oil on cutaneous angiogenesis induced in Balb/c mice by syngeneic sarcoma L-1, human urinary bladder and human kidney tumor cells
18. Lymphocyte-induced angiogenesis a quantitive and sensitive assay of the graft-vs-host reaction
19. Screening of angiogenesis inhibitors by modified tumor-induced angiogenesis (TIA) test in lung cancer
20. Inhibition of angiogenesis by sulindac and its sufone metabolite (FGN-1): A potential mechanism for their antineoplastic properties
21. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites
22. The angiogenic factor interleukin 8 is induced in non- small cell lung cancer/pulmonary fibroblast cocultures
23. Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer
24. N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis
25. Vascular endothelial growth factor: An important angiogenic madiator in bladder cancer
26. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma
27. Nuclear 24kD fibroblast growth factor (FGF)-2 confers metastatic properties on rat bladder carcinoma cells
28. Basic fibroblast growth factor enhanced LAK cell cytotoxicities aganist human bladder neoplasm cells
29. Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer
30. Serum conentrations of VEGF and bFGF in renal cell, prostate and utinary bladder carcinomas